Onderneming BBI Life Sciences Corporation
Aandelen
1035
KYG1089Y1180
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Luo Jia Wang
CEO | Chief Executive Officer | 55 | - |
Xiao Lei Gu
DFI | Director of Finance/CFO | 43 | 11-09-15 |
Jin Wang
PSD | President | 53 | - |
Bin Liu
BRD | Director/Board Member | 41 | 30-10-19 |
Mi Zhou
BRD | Director/Board Member | 41 | - |
Heng Hu
SEC | Corporate Secretary | 44 | - |
Sau Mei Ng
SEC | Corporate Secretary | 47 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Qi Song Wang
CHM | Chairman | 83 | - |
Jian Jun Liu
BRD | Director/Board Member | 56 | 16-01-14 |
Luo Jia Wang
CEO | Chief Executive Officer | 55 | - |
Jin Wang
PSD | President | 53 | - |
Mi Zhou
BRD | Director/Board Member | 41 | - |
Bin Liu
BRD | Director/Board Member | 41 | 30-10-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 560 522 623 | 249 121 411 ( 44,44 %) | 0 | 44,44 % |
Bedrijfsgegevens
BBI Life Sciences Corp.
No. 698, Xiangmin Road Songjiang District
201611, Shanghai
+
http://www.bbi-lifesciences.com![Adres BBI Life Sciences Corporation(1035)](https://cdn.zonebourse.com/static/address/19345372.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+38,65% | 39,36 mld. | |
-8,62% | 38,52 mld. | |
+26,95% | 30,74 mld. | |
+10,74% | 25,92 mld. | |
-13,50% | 26,03 mld. | |
+44,87% | 14,13 mld. | |
+34,36% | 12,73 mld. | |
-7,14% | 11,29 mld. | |
-12,61% | 10,64 mld. |